| Financial Year |
March 31 2023 |
| Monetary Funds |
170,839,759.00 |
| Held-for-trading Financial Assets |
48,234,050.00 |
| Notes Receivable |
73,389,093.54 |
| Accounts Receivable |
113,669,647.07 |
| Advances to Suppliers |
6,104,942.23 |
| Other Receivables |
5,773,999.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
435,336,844.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
175,651,220.45 |
| Total Current Assets |
1,112,571,295.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
15,982,408.68 |
| Fixed Assetes |
141,535,164.95 |
| Under-construction Projects |
15,196,477.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,470,325.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,278,681.98 |
| Deferred Income Tax Assets |
11,709,479.56 |
| Other Non-Current Assets |
4,852,676.28 |
| Sub-Total of Non-Current Assets |
266,621,754.10 |
| Total Assets |
1,379,193,049.18 |
| Short-Term Loans |
16,009,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
71,923,703.31 |
| Accounts Payable |
123,729,464.28 |
| Accounts Received In Advance |
3,666,001.38 |
| Employee Compensation Payable |
21,646,250.15 |
| Taxes Payable |
14,220,500.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,019,632.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
569,485.64 |
| Other Current Liabilities |
52,754,274.60 |
| Sub-Total of Current Liabilities |
683,746,886.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,388,123.23 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,866,045.89 |
| Total Liabilities |
690,612,932.54 |
| Paid-In Capital(Or Share Stock) |
438,025,420.00 |
| Capital Surplus |
33,141,711.01 |
| Surplus Reserve |
67,013,838.91 |
| LESS:Treasury Stock |
28,502,027.40 |
| Undistributed Profits |
170,100,258.88 |
| Minority Stockholder's Interest |
8,815,457.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
679,764,659.10 |
| Owner's Equity（Stockholder's Equity） |
688,580,116.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,379,193,049.18 |
